Ladenburg Thalmann has recently reduced CNS Pharmaceuticals Inc (CNSP) stock to Neutral rating, as announced on December 28, 2020, according to Finviz. Analyst ratings are significant because they ...
Ladenburg Thalmann has recently reduced CNS Pharmaceuticals Inc (CNSP) stock to Neutral rating, as announced on December 28, 2020, according to Finviz. Analyst ratings are significant because they ...
HOUSTON, TX / ACCESSWIRE / September 12, 2024 / CNS Pharmaceuticals, Inc. (NASDAQ:CNSP)("CNS" or the "Company"), a biopharmaceutical company specializing in the development of novel treatments for ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...